Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

NCT00303407 · clinicaltrials.gov ↗

TERMINATED

Status

OTHER

Sponsor class

Conditions

Cancer
Venous Thromboembolism

Interventions

DRUG: nadroparin

Sponsor

University Hospital, Geneva